Adding camrelizumab and rivoceranib to transarterial chemoembolization (TACE) significantly prolonged progression-free ...
News Medical on MSN2h
Innovating for impact: Jordi Labs on aligning methodologies with FDA expectationNews-Medical speaks with Jordi Labs’ about its recent achievements, alignment with FDA expectations, and strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback